PTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical Hold

Submitted by admin on June 20, 2024 - 6:00pm

Source:

BioSpace

News Tags:

PTC Therapeutics

Huntington's disease

PTC518

clinical trials

Headline:

PTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical Hold

snippet:

PTC Therapeutics announced Thursday that its Huntington’s disease candidate PTC518 is no longer subject to an FDA partial clinical hold after it showed positive interim results from a Phase II study.

Search form

You are here

PTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical Hold

PTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical Hold